1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Total Occlusion Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution /Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Sales Analysis of Major Micro Catheter Brands, 2022
    5.2. Sales Analysis of Major Guide Wires Brands, 2022
    5.3. Sales Analysis of Major Crossing Device Brands, 2022
    5.4. Technological Advancements
    5.5. Disease Prevalence & Incidence Rate globally with key countries
    5.6. Regulatory Scenario by Region/globally
    5.7. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017-2031
        6.3.1. Microcatheters
        6.3.2. Guidewires
        6.3.3. Balloon Catheters
        6.3.4. Crossing Devices
        6.3.5. Stents
        6.3.6. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by End-user, 2017-2031
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by End-user
8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Total Occlusion Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Product Type, 2017-2031
        9.2.1. Microcatheters
        9.2.2. Guidewires
        9.2.3. Balloon Catheters
        9.2.4. Crossing Devices
        9.2.5. Stents
        9.2.6. Others
    9.3. Market Value Forecast, by End-user, 2017-2031
        9.3.1. Hospitals
        9.3.2. Ambulatory Surgical Centers
        9.3.3. Others
    9.4. Market Value Forecast, by Country, 2017-2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017-2031
        10.2.1. Microcatheters
        10.2.2. Guidewires
        10.2.3. Balloon Catheters
        10.2.4. Crossing Devices
        10.2.5. Stents
        10.2.6. Others
    10.3. Market Value Forecast, by End-user, 2017-2031
        10.3.1. Hospitals
        10.3.2. Ambulatory Surgical Centers
        10.3.3. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017-2031
        11.2.1. Microcatheters
        11.2.2. Guidewires
        11.2.3. Balloon Catheters
        11.2.4. Crossing Devices
        11.2.5. Stents
        11.2.6. Others
    11.3. Market Value Forecast, by End-user, 2017-2031
        11.3.1. Hospitals
        11.3.2. Ambulatory Surgical Centers
        11.3.3. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017-2031
        12.2.1. Microcatheters
        12.2.2. Guidewires
        12.2.3. Balloon Catheters
        12.2.4. Crossing Devices
        12.2.5. Stents
        12.2.6. Others
    12.3. Market Value Forecast, by End-user, 2017-2031
        12.3.1. Hospitals
        12.3.2. Ambulatory Surgical Centers
        12.3.3. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017-2031
        13.2.1. Microcatheters
        13.2.2. Guidewires
        13.2.3. Balloon Catheters
        13.2.4. Crossing Devices
        13.2.5. Stents
        13.2.6. Others
    13.3. Market Value Forecast, by End-user, 2017-2031
        13.3.1. Hospitals
        13.3.2. Ambulatory Surgical Centers
        13.3.3. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competition Matrix (by tier and size of companies)
    14.2. Market Share Analysis, by Company, 2022
    14.3. Company Profiles
        14.3.1. Medtronic
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Type Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Boston Scientific Corporation
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Type Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Abbott
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Type Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Asahi Intecc Co., Ltd
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Type Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Acrostak Int. Distr. Sàrl
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Type Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Cook Medical
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Type Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Koninklijke Philips N.V
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Type Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Terumo Corporation
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Type Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
            14.3.8.5. Strategic Overview
        14.3.9. Teleflex Incorporated
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Type Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
            14.3.9.5. Strategic Overview
        14.3.10. Becton, Dickinson and Company
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Type Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview
        14.3.11. Reflow Medical, Inc.
            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.11.2. Product Type Portfolio
            14.3.11.3. Financial Overview
            14.3.11.4. SWOT Analysis
            14.3.11.5. Strategic Overview
        14.3.12. Cordis
            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.12.2. Product Type Portfolio
            14.3.12.3. Financial Overview
            14.3.12.4. SWOT Analysis
            14.3.12.5. Strategic Overview
Table 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			